Walleye Capital LLC Cytek Biosciences, Inc. Transaction History

Walleye Capital LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$5.52 - $9.5 $85,416 - $147,003	15,474 New	15,474 $85,000
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $748,231 - $1.19 Million	-88,653 Reduced 82.51%	18,790 $172,000
Q4 2022 Feb 14, 2023	BUY	$9.71 - $15.86 $902,049 - $1.47 Million	92,899 Added 638.74%	107,443 $1.1 Million
Q3 2022 Nov 14, 2022	BUY	$10.96 - $15.45 $159,402 - $224,704	14,544 New	14,544 $214,000
Q2 2022 Aug 08, 2022	SELL	$7.41 - $11.56 $725,083 - $1.13 Million	-97,852 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $316,796 - $552,552	32,032 Added 48.67%	97,852 $1.06 Million
Q4 2021 Mar 03, 2022	BUY	$16.14 - $25.04 $733,078 - $1.14 Million	45,420 Added 222.65%	65,820 $1.07 Million
Q3 2021 Nov 15, 2021	BUY	$17.52 - $27.93 $357,408 - $569,772	20,400 New	20,400 $437,000

134

71.7M

400

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $874M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Capital LLC with notifications on news.